Related Experiment Video
Updated: Feb 6, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Outcomes in patients undergoing cardiac resynchronisation therapy complicated by device-related infective
Ewa Jędrzejczyk-Patej1, Michał Mazurek, Oskar Kowalski
1Department of Cardiology, Congenital Heart Diseases and Electrotherapy, Silesian Centre for Heart Diseases, Zabrze, Poland. ewajczyk@op.pl.
Insights
Cardiac device-related infective endocarditis (CDRIE) is a serious complication of cardiac resynchronisation therapy (CRT). Early device removal significantly reduces mortality in CRT patients with CDRIE.
Area of Science:
- Cardiology
- Infectious Diseases
Background:
- Cardiac device-related infective endocarditis (CDRIE) is a severe complication of cardiac resynchronisation therapy (CRT).
- Assessing outcomes in CRT patients with CDRIE is crucial for improving patient management.
Purpose of the Study:
- To evaluate clinical outcomes in patients with CRT who develop CDRIE.
- To identify factors influencing mortality in CRT patients with CDRIE.
Main Methods:
- A retrospective analysis of 765 CRT implantations between 2002 and 2015.
- CDRIE cases were identified using modified Duke criteria.
- Clinical outcomes and mortality predictors were assessed through multivariate regression analysis.
Main Results:
- CDRIE was diagnosed in 5.4% of CRT patients, with a high overall mortality rate (75.6%).
- Device explantation was associated with significantly lower in-hospital mortality (39.3% vs. 76.9%, p=0.025).
- Independent predictors of mortality included need for temporary pacing, delayed device removal (>7 days), and acute kidney injury.
Conclusions:
- Device removal is independently associated with reduced mortality in CRT patients with CDRIE.
- Early device removal, absence of need for temporary pacing post-explantation, and normal renal function are associated with better outcomes.
Background:
Cardiac device-related infective endocarditis (CDRIE) is one of the most serious complications of cardiac resynchronisation therapy (CRT).
Aim:
We sought to assess clinical outcomes and their determinants in CRT patients with CDRIE.
Methods:
A tertiary cardiology centre database was screened to identify all CDRIE cases, diagnosed based on the modified Duke criteria, amongst 765 consecutive CRT implantations performed between 2002 and 2015 (70.8% de novo implantations, 29.2% upgrades).
Results:
During the median follow-up of 1692 days (range: 457-3067 days) CDRIE was diagnosed in 41 (5.4%) patients. Overall, in-hospital and long-term mortality rates of CDRIE patients were 51.2% and 75.6%, respectively. Among patients with CDRIE, in whom the device was vs. was not explanted, in-hospital death rates were 39.3% (11/28 patients) vs. 76.9% (10/13 patients; p = 0.025). In multivariate regression analysis, device removal was independently associated with significantly lower in-hospital mortality (hazard ratio [HR] 0.09, 95% confidence interval [CI] 0.03-0.35, p = 0.0004). The need for temporary pacing after device removal (HR 5.92, 95% CI 1.13-30.96, p = 0.035), a time period of less than seven days between CDRIE diagnosis and CRT removal (HR 6.69, 95% CI 1.48-30.27, p = 0.01), and the highest serum creatinine level during infection (HR 1.02, 95% CI 1.004-1.03, p = 0.01) were identified as independent predictors of higher in-hospital mortality.
Conclusions:
Device removal is independently associated with lower mortality in patients with CRT and CDRIE. Early device removal (less than seven days since the diagnosis), the need for temporary pacing after removal and acute renal failure are independent mortality predictors in CRT patients who developed CDRIE.
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis I: Introduction
Hemodialysis II: Procedure and Complications
Predicting Reaction Outcomes
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management

